1. Introduction {#sec0005}
===============

Natural products are accomplished as important compounds which exhibit many applications in the fields of medicine, pharmacy and agriculture. Majority of antibiotics used for the treatment of various infectious diseases, are originated from microbial natural products. Starting from the discovery of penicillin in 1928, studies have shown that microorganisms are rich source of structurally unique bioactive substances \[[@bib0005]\]. In present scenario as Multi Drug Resistance is a major threat to society, search for new drugs is indispensable all over the world \[[@bib0010]\].

Biosurfactants are amphipathic molecules possessing immense structural diversity, biodegradability and less toxicity compared to synthetic ones \[[@bib0015]\]. Various microbes are known to produce different kinds of biosurfactants. Lipopeptide types are synthesized by *Bacillus* and other species, glycolipids types are synthesized by *Pseudomonas* and *Candida* species \[[@bib0020]\]. *Pseudomonas aeruginosa* has been known to produce rhamnolipid type of biosurfactant having different biological properties \[[@bib0025]\]. Surfactin, an important antimicrobial and antifungal agent is known to be produced from *Bacillus subtilis* \[[@bib0030]\]. Very recently *Joanna et al*., have reported a nonspecific synergistic antibacterial and anti-fungal effect of biogenic silver nanoparticles and biosurfactant produced by *Bacillus subtilis* towards environmental bacteria and fungi \[[@bib0035]\]. *Lactobacillus species* also produces biosurfactant that can contribute to the bacteria's ability to prevent microbial infections associated with urogenital and gastrointestinal tracts and the skin \[[@bib0040]\]. Biosurfactants can replace synthetic surfactants and have potential biomedical, industrial and environmental applications and can be used as potential antibiotic agents as highlighted by *Rodrigues et.al.* \[[@bib0045]\]. Their potential application in products for human consumption such as biomedical, cosmetics, pharmaceuticals or as food additives requires an accurate characterization of possible toxic side effects \[[@bib0050]\].

The *Candida parapsilosis* family has emerged as a major opportunistic and nosocomial pathogen. It causes multifaceted pathology in immuno-compromised and normal hosts, notably low birth weight neonates. This fungus has emerged as major causes of human disease, particularly among immuno-compromised individuals and hospitalized patients with serious underlying conditions. Many microbes such as *Pseudomonas, Bacillus, Azospirillum* and *Rhizobium* were once considered to be toxic but over a period of time, many changes were made in the genes of these microbes and now they are exploited for commercial value products \[[@bib0055],[@bib0060]\]. Different *Candida sp.* are already known to produce sophorolipids which are extracellular glycolipids \[[@bib0065]\]. Sophorolipids are the most common biosurfactants used in cosmetics and therapeutics \[[@bib0070]\]. Mannosyl erythritol lipid (MEL), a yeast glycolipid biosurfactant produced from vegetable oils by *Candida* strains has already been reported \[[@bib0075]\].

Present study describes the isolation of *Candida parapsilosis* from a contaminated dairy product. This is the first study which reports the ability of *C. parapsilosis* to produce biosurfactant. The organism was identified through morphology and sequencing studies. The biosurfactant was characterized and its potential antibacterial activity was explored.

2. Material and methods {#sec0010}
=======================

2.1. Chemicals and Reagents {#sec0015}
---------------------------

The potato dextrose broth (PDB), potato dextrose agar (PDA), nutrient agar media, glycerol and Phosphate Buffer Saline (pH 7) were purchased from HiMedia, Mumbai, India. All reagents used were of molecular biology grade unless mentioned and used as obtained. The bacterial cultures of *Escherichia coli* MTCC No. 1687 and *Staphylococcus aureus* MTCC No. 96 were procured from Microbial Type Culture Collection (MTCC, IMTECH, Chandigarh, India).

2.2. Microorganism and culture conditions {#sec0020}
-----------------------------------------

The microorganism was isolated from contaminated dairy products and grown in potato dextrose broth. The microbial culture was sub-cultured twice in PDB broth at 37 °C for 24 h. The strain was kept frozen at −80 °C in PDB broth containing 30% (v/v) glycerol solution until required. Both the test strains of *E. coli* and *S. aureus* were activated twice in nutrient broth at 37 °C for 24 h.

3. Molecular Characterization of the organism {#sec0025}
=============================================

3.1. MALDI Biotyper {#sec0030}
-------------------

The colony was analyzed by MALDI Biotyper (Bruker, Germany) \[[@bib0080]\]. The isolated single colony was transferred onto MALDI Biotyper Steel plate using a sterile loop and was analyzed.

3.2. Molecular Characterization {#sec0035}
-------------------------------

The molecular characterization report was provided by MTCC, Chandigarh, India. Based on the 26 S rRNA, 18 S rRNA, 28 S rRNA and ITS region sequence, the organism was identified.

3.3. Extraction of biosurfactant {#sec0040}
--------------------------------

The biosurfactant was extracted from cell-free broth of 72 hour grown cells. To extract the biosurfactant, cell-free supernatants were subjected to acid precipitation by subjecting supernatants to pH 2.0 with 6 N HCl. Afterwards, the precipitate was collected by centrifugation and pH was adjusted at 7.0. Finally, the biosurfactant solution was freeze-dried \[[@bib0085]\].

3.4. Screening of biosurfactant {#sec0045}
-------------------------------

Different biosurfactant screening methods were performed to check the presence of potential biosurfactant. The methods adopted were (a) drop-collapse test \[[@bib0090]\]; (b) Oil spreading technique \[[@bib0095]\]; (c) Emulsification activity \[[@bib0100]\] and (d) Hemolytic activity in 5% blood agar plate \[[@bib0095]\].

4. Characterization of biosurfactant {#sec0050}
====================================

4.1. Fourier Transform Infrared Spectroscopy (FTIR) {#sec0055}
---------------------------------------------------

FTIR spectroscopy (Perkin Elmer-Spectrum RX-IFTIR, U.S.A.) was carried out using crude biosurfactant extract obtained from the acid precipitation of the cell free culture supernatant. The FTIR spectrum, with a resolution of 4 cm^-1^, was collected from 400 to 4000 cm^-1^. The basic functional groups of the biosurfactant were analyzed \[[@bib0085]\].

4.2. Gas Chromatography- Mass Spectroscopy (GC-MS) {#sec0060}
--------------------------------------------------

GC-MS (Thermo Scientific TSQ 8000 Gas Chromatograph - Mass Spectrometer, U.S.A.) of partially purified biosurfactant was analyzed using gas chromatography. Helium was used as carrier gas with the flow rate of 1.0 ml min^-1^. The initial column temperature was 100 °C for 1 min, then ramped at 30 °C to 270 °C, and finally held at 270 °C for 10 min. The temperatures of the inlet temperature, transfer line, ion trap, and quadruple were 270, 280, 230, and 150 °C, respectively \[[@bib0105]\].

5. Antibacterial activity {#sec0065}
=========================

5.1. Agar diffusion method {#sec0070}
--------------------------

Nutrient Agar media was prepared. Plates were swabbed with *E.coli* and *S. aureus* cultures. Wells were made in the agar plates using a sterile well maker and then various concentrations of biosurfactant (0.3, 0.75, 1.50 mg ml^-1^) were added in separate well. The plates were kept in incubation at 37° C for 24 h. The clear zone diameter was noted \[[@bib0110]\].

5.2. Micro dilution method {#sec0075}
--------------------------

The antibacterial activity of the biosurfactant was examined against the bacterial strains using micro dilution method \[[@bib0115]\]. Both the strains were cultured individually on nutrient broth at 37 °C overnight under aerobic conditions and the inoculums of each strain was adjusted to a concentration of 10^8^ CFU ml^-1^ which corresponds to 0.50 McFarland Turbidity Standards \[[@bib0120]\]. The assay was carried out in a 96-well flat bottom polystyrene micro titer plates with lids. The first column of the well plate was filled with 125 μl of sterile double strength nutrient broth and the remaining columns were filled with single-strength nutrient broth. Subsequently, 125 μl of biosurfactant solution prepared using phosphate buffer saline (pH 7) at a concentration of 40 mg ml^-1^ was added to the first column and mixed with the medium, then serially diluted to the subsequent wells to attain a biosurfactant concentration ranging from 5 mg ml^-1^ to 20 mg ml^-1^. Growth controls were also there. The inoculated well plates were covered with lids and incubated at 37° C overnight. After incubation, the absorbance was recorded at 600 nm for each well using a microplate reader (iMARK^TM^ Microplate Absorbance Reader, Bio-Rad, USA). The assays were performed in triplicate.

6. Results and Discussion {#sec0080}
=========================

6.1. Characterization of organism {#sec0085}
---------------------------------

### 6.1.1. MALDI Biotyper {#sec0090}

MALDI Biotyper is a rapid, inexpensive and at the same time very reliable tool for microbe identification \[[@bib0125]\]. The microbe was identified as *Candida parapsilosis by* MALDI Biotyper. However, the identification of isolate was further supported by 18 S rRNA gene sequencing.

### 6.1.2. Molecular characterization {#sec0095}

As identified by the MALDI Biotyper, the isolate was an yeast and hence a 18 S rRNA gene sequencing was done \[[@bib0130]\]. Based on the 26 S rRNA, 18 S rRNA, 28 S rRNA and ITS region sequence, the organism was identified as *C. parapsilosis.* Comparative sequence analysis of the 18 S rRNA (690 bp) in the GenBank database was performed by a BLAST search and manually reading through the GenBank accession number as shown in [Fig. 1](#fig0005){ref-type="fig"}. The gene sequence comparison demonstrated 100% similarities to *Candida parapsilosis*. Hence, MALDI Biotyper and molecular characterization data showed that the isolate was *Candida parapsilosis.*Fig. 1Identification of *Candida parapsilosis* based on the 26 S rRNA, 18 S rRNA, 28 S rRNA and ITS region sequence through BLAST. Phylogenetic tree was generated using tools from NCBI.Fig. 1

### 6.1.3. Screening of biosurfactant {#sec0100}

Different biosurfactant screening tests such as drop collapse test, oil spreading test, emulsification activity and hemolytic activity confirmed that *C. parapsilosis* was able to produce biosurfactant as shown in [Table 1](#tbl0005){ref-type="table"}. The drop on the surface of oil coated wells collapsed which showed the presence of biosurfactant in the media. A clear zone was observed in the oil-water surface which confirmed presence of biosurfactant in oil spreading test. In emulsification index, the heights of each layer were taken and changes in the heights were noted after the settling periods. The methodology used and results obtained are well supported by the already available reports of biosurfactant screening \[[@bib0135], [@bib0140], [@bib0145], [@bib0150]\]. The current result of blood hemolysis was well corroborated with the report of *Luo. et al.* where tested isolates of *C. parapsilosis* neither showed α-hemolysis nor showed β-hemolysis even after 72 hours of incubation \[[@bib0155]\]. Screening methods such as drop collapse test, oil spreading test, emulsification activity and hemolytic activity are generally used as simple tools for the screening of the biosurfactant. The isolated biosurfactant showed gamma hemolysis but results are positive for drop collapse test, oil spreading test, emulsification activity. The absence of hemolytic activity (γ- hemolysis) could be due to diffusion restriction of the surfactant through the blood agar \[[@bib0160]\]. These assays are performed based on surface activity measurements and are well accepted as preliminary screening method of biosurfactants \[[@bib0095]\].Table 1Table shows screening results for biosurfactant.Table 1Screening testResultOil spreading assayPositiveDrop collapse methodPositiveEmulsifying indexPositiveHemolysisNegative

6.2. Characterization of biosurfactant {#sec0105}
--------------------------------------

### 6.2.1. FTIR spectroscopy {#sec0110}

The different peak of the IR spectral analysis shown in [Fig. 2](#fig0010){ref-type="fig"} revealed that, the stretch, 3409 cm^-1^ denoted as O-H group. The presence of this peak revealed the fact that the sample contains phenol or alcohol group. C = O bond stretching resulted peak at 1724 cm^-1^.The peak at 1638 cm^-1^ corresponded to N-H which could be due to an amide in the sample. The presence of the peak at 1403 cm^-1^ confirmed the presence of C = C. These functional groups were similar to previously reported biosurfactants produced by various other *Candida sp* \[[@bib0165], [@bib0170], [@bib0175], [@bib0180]\].Fig. 2FTIR spectrum of the biosurfactant.Fig. 2

6.3. Gas Chromatography--Mass Spectrometry {#sec0115}
------------------------------------------

After performing the GC MS of the biosurfactant as shown in [Fig. 3](#fig0015){ref-type="fig"}, major peaks were obtained at retention times of 4.27, 27.17, 27.57, 27.31 minute. The most dominant peak was that obtained at 27.57 min. The MS of this eluent was done by the system and the peaks obtained were matched with the system library. The molecule obtained at this retention time is 13-Docosenamide.The molecular weight of 13- Docosenamide is 337.5 g/mol and its characteristic MS spectra is shown in [Fig. 3](#fig0015){ref-type="fig"}. GC-MS result shows the presence of 13-Docosenamide residues which correlates with other reports. This data corroborates with the FTIR of the biosurfactant produced in this study. The peaks corresponding to the functional groups obtained in the FTIR are present in docosenamide. This is the only third report after *Donio et.al*. and *Conde-Martínez et.al.* which showed docosenamide as a biosurfactant \[[@bib0085],[@bib0185]\].Fig. 3Graphs obtained from GC-MS, (a) shows GC whereas (b) shows MS at Retention time of 27.57 minutes. The molecule identified through library search was found to be 13-Docosenamide.Fig. 3

6.4. Antibacterial activity {#sec0120}
---------------------------

### 6.4.1. Agar diffusion method {#sec0125}

Partially purified biosurfactant from *C. parapsilosis*, showed antibacterial activity against bacterial pathogens, *E. coli* and *S. aureus* (From [Table 2](#tbl0010){ref-type="table"}). In well diffusion assay, biosurfactant produced a zone of inhibition against *S. aureus* and *E.coli*. Higher concentrations of biosurfactant led to increase in the diameter of zone of inhibition. Higher concentrations of biosurfactant led to increase in the diameter of zone of inhibition. Maximum zone of inhibition was observed at biosurfactant concentration of 1.5 mg ml^-1^ wherein, it was approximately 2.87 cm for *E. coli* and 2.66 cm for *S. aureus*.Table 2Effect of different concentrations of biosurfactant against *E. coli* and *S. aureus* measured by zone of inhibition diameter.Table 2Concentration of biosurfactant(mg ml^-1^)Zone of inhibition diameter (in cm) mean (For *E. coli*)Zone of inhibition diameter (in cm) mean (For *S. aureus*)0.302.19 ± 0.0422.22 ± 0.0090.752.45 ± 0.0312.39 ± 0.0041.502.87 ± 0.0482.66 ± 0.012

Zone of inhibition diameters were found to be more for *E. coli* than *S. aureus.* The antibacterial results with current biosurfactant were comparable with those obtained from previous reports \[[@bib0190], [@bib0195], [@bib0200]\].

### 6.4.2. Microdilution method {#sec0130}

The isolated biosurfactant was checked for antibacterial effects on *E. coli* and *S. aureus* by micro-dilution method also. The absorbance was recorded at 600 nm for each well using a microplate reader and is shown in [Table 3](#tbl0015){ref-type="table"}.The crude biosurfactant isolated from *Candida sphaerica* showed the antimicrobial activity with concentrations between 5 and 10 mg ml^-1^ against *C. albicans, Staphylococcus aureus* and *Staphylococcus epidermidis* \[[@bib0205]\]. A biosurfactant concentration between 25 and 50 mg ml^−1^ was required for antimicrobial activity against pathogenic *Candida albicans, Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis* and *Streptococcus agalactiae* \[[@bib0210]\].These reports provided additional support to our current results which demonstrated that biosurfactant isolated from *C. parapsilosis* showed antibacterial activity against *E. coli* and *S. aureus* at the concentrations of 10 and 5 mg ml^-1^ respectively.Table 3Growth inhibition obtained with the crude at different concentrations (mg ml^-1^). Results are expressed as means ± standard deviations of values obtained from triplicate experiments.Table 3OrganismBiosurfactant concentration(mg ml^-1^)O.D at 600 nm (mean)*E. coli*Control0.899 ± 0.0100050.380 ± 0.0130100.180 ± 0.0040200.090 ± 0.0062*S. aureus*Control0.912 ± 0.0030050.240 ± 0.0140100.085 ± 0.0157200.050 ± 0.0085

7. Conclusion {#sec0135}
=============

In the present study, biosurfactant was isolated from *C. parapsilosis* and partially characterized.The isolated biosurfactant showed the potential of an antibacterial agent. The experiments of this study suggested that *C. parapsilosis* can be explored for some beneficial uses in biopharmaceutics, therapeutics apart from their pathogenicity. Although the mode of action of biosurfactant is not clear now, but some reports have shown to disrupt plasma membrane of the cells and more studies need to be carried out to get a clear insight in this regard \[[@bib0215]\].
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